Greg H Gardella
President at Gardella Grace PA
Greg H Gardella has handled some of the highest stakes post-grant matters ever adjudicated by the US Patent and Trademark Office. He has regularly served as lead counsel for both challengers and patent owners in matters with stakes running in to the billions of dollars. For instance, he successfully defended the famous TiVo DVR patent which thereafter generated well over $1 billion in licensing revenue. Mr Gardella also successfully defended before the Patent Trial and Appeal Board four patents covering aseptic packaging technologies which are used to process approximately two billion bottles per year. On the challenger side, he prevailed for St Jude Medical in nine post-grant proceedings targeting numerous Medtronic patents which had purported to cover the billion-dollar renal denervation industry. In those cases, every challenged claim was finally found invalid on multiple grounds.
Mr Gardella has been honoured by Best Lawyers in America for multiple consecutive years. He has also been named repeatedly by IAM as one of the nation’s top post-grant practitioners. IAM reported that “the ‘phenomenal’ Greg H Gardella is extremely experienced in the post-grant space and a dynamic all-round patent consultant” and noted that his “former big-ticket patent litigation experience has served him well in contested reexamination proceedings, of which he is regarded a master”. He has also received various awards and recognition from Managing IP Magazine, Super Lawyers and Who’s Who Legal.
Mr Gardella was also the editor of a treatise on post-grant practice entitled Post Grant Proceedings Before the Patent Trial and Appeal Board, published by Practising Law Institute. He has frequently lectured on post-grant proceedings and strategies for effective execution of concurrent litigation, post-grant proceedings and patent prosecution.
Mr Gardella has broad technical aptitude arising from his dual degrees in electrical and mechanical engineering and from years of representations involving DNA detection and sequencing, genetic diagnosis and screening, organic chemistry, immunochemistry, pharmaceutical and other biotechnology innovations. Mr Gardella is familiar with the technologies underlying most medical devices, polymerisation processes, genetic sequencing techniques, semiconductor fabrication and device structure, computer architecture, wireless telecommunications, network data communication, software ranging from microcode to application layer, signal processing, VLSI design, micro-structured films and industrial equipment.